MRK Merck & Company Inc.
- 38.64 P/E
- 3.92 P/S
- 3.43 P/B
- 1.516 EPS
- 10.80% Cash ROIC
- 0.98 Cash Ratio
- 1.75 / 2.99% Dividend
- 8.83M Avg. Vol.
- 2.92B Shares
- 170.1B Market Cap.
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company's Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, ...
Reuters - Jul 29, 2014
Merck 2Q profit more than doubles - Sydney Morning Herald
StreetInsider.com (subscription) - Jul 29, 2014
Merck & Co., Inc. Posts Higher Q2 Profits; Revenue Declines; Beats Estimates ... - Dividend.com
ETF Daily News (blog) - 14 hours ago
ETF Daily News (blog) - 19 hours ago
Seeking Alpha (registration) - Jul 28, 2014
The Times Herald - Jul 25, 2014
Schaeffers Research (blog) - Jul 28, 2014
Intercooler - Jul 30, 2014
Seeking Alpha (registration) - Jul 29, 2014
Jutia Group - Jul 28, 2014